Waters Corporation

Waters Corporation, headquartered in Milford, Massachusetts, is a highly specialized, deeply respected global pioneer and absolute leader in the extremely complex fields of analytical sciences. While some competitors offer broadly diversified laboratory portfolios, Waters consistently distinguishes itself through intense, highly focused expertise. Operating as a critical partner to the global scientific community, the company generated $3.165 billion in annual revenue in 2025, fundamentally powering advanced research across the pharmaceutical, clinical, food safety, and materials science sectors.

The organization fundamentally revolutionized modern analytical chemistry with the pioneering invention of ultra-performance liquid chromatography (UPLC). The renowned ACQUITY UPLC systems significantly increase the speed, sensitivity, and massive resolution of complex chemical separations compared to traditional HPLC methodologies. When coupled with Waters’ highly sophisticated mass spectrometers, these instruments become strictly essential in modern pharmaceutical R&D—heavily relied upon by scientists to precisely identify complex metabolites, characterize large, fragile biologic drugs, and perform rigorous quality control.